7,11-(butane-1,4-diyldioxydi-o-phenylenedimethylene)-6,6-dichloro-4,4-bis(pyrrolidin-1-yl)-2 lambda(5),4 lambda(5),6 lambda(5)-triphosphaza-1,3,5,7,11-pentaazaspiro[5.5] undeca-1,3,5-triene

TERCAN, B; Hokelek, TUNCER; BUYUKGUNGOR, O; ASMAFILIZ, N; ILTER, EE; KILIC, Z

doi:10.1107/s1600536805018362

7,11-(butane-1,4-diyldioxydi-o-phenylenedimethylene)-6,6-dichloro-4,4-bis(pyrrolidin-1-yl)-2 lambda(5),4 lambda(5),6 lambda(5)-triphosphaza-1,3,5,7,11-pentaazaspiro[5.5] undeca-1,3,5-triene

Atıf İçin Kopyala

TERCAN B., Hokelek T., BUYUKGUNGOR O., ASMAFILIZ N., ILTER E., KILIC Z.

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, cilt.61, 2005 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 61
Basım Tarihi: 2005
Doi Numarası: 10.1107/s1600536805018362
Dergi Adı: ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
Hacettepe Üniversitesi Adresli: Evet

Özet

The title compound, C29H42Cl2N7O2P3, is a phosphazene derivative with a bulky substituent attached through a spiro junction with two pyrrolidine rings. The six-membered C3N2P ring has a chair conformation, while the phosphazene ring has a slight envelope conformation. The two N atoms in the C3N2P ring are likely to be stereogenic.